Chronic HMG-CoA Reductase Inhibitor Treatment Contributes to Dysglycemia by Up-Regulating Hepatic Gluconeogenesis through Autophagy Induction

被引：0
|
作者：
Wang, Hye Jin
Park, Jae Yeo
Choe, Eun Yeong
Kwon, Obin
Lee, Yong-Ho
Kim, Gyuri
Bae, Jaehyun
Park, Se Hee
Yun, Yu Jung
Yun, Mijin
Kim, Chul Hoon
Lee, Hyangkyu
Kim, Young Bum
Kang, Eun Seok
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1787-P
引用
收藏
页码：A461 / A461
页数：1
相关论文
共 50 条
  • [1] Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction
    Wang, Hye Jin
    Park, Jae Yeo
    Kwon, Obin
    Choe, Eun Yeong
    Kim, Chul Hoon
    Hur, Kyu Yeon
    Lee, Myung-Shik
    Yun, Mijin
    Cha, Bong Soo
    Kim, Young-Bum
    Lee, Hyangkyu
    Kang, Eun Seok
    AUTOPHAGY, 2015, 11 (11) : 2089 - 2101
  • [2] Chronic HMG-Co Reductase Inhibitor (Statin) Treatment Contributes to Dysglycemia by Upregulating Hepatic Gluconeognesis via Autophagy Induction
    Wang, Hye Jin
    Park, Jae Yeo
    Choe, Eun Yeong
    Kwon, Obin
    Jeon, Jeong Yong
    Cho, Yongin
    Yun, Yu Jung
    Kim, Chul Hoon
    Yun, Mijin
    Lee, Byung-Wan
    Cha, Bong Soo
    Lee, Hyun Chul
    Lee, Hangkyu
    Kang, Eun Seok
    DIABETES, 2013, 62 : A483 - A483
  • [3] HYPERKALEMIA DURING TREATMENT WITH HMG-COA REDUCTASE INHIBITOR
    EDELMAN, S
    WITZTUM, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18): : 1219 - 1220
  • [4] HMG-CoA reductase inhibitor treatment in renal insufficiency
    Wanner, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (10) : 1951 - 1952
  • [5] Chronic creatine kinase elevation not associated with HMG-CoA reductase inhibitor treatment
    Lin, JC
    Ito, MK
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (02) : 163 - 166
  • [6] HYPERKALEMIA DURING TREATMENT WITH HMG-COA REDUCTASE INHIBITOR - REPLY
    GRUNDY, SM
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18): : 1220 - 1220
  • [7] Pitavastatin A New HMG-CoA Reductase Inhibitor for the Treatment of Hypercholesterolemia
    Ahmad, Haniyyah
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2010, 18 (05) : 264 - 267
  • [8] FOCUS ON PRAVASTATIN - AN HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
    BROISMAN, L
    ENGSTER, P
    CHOW, MSS
    HOSPITAL FORMULARY, 1991, 26 (07): : 552 - 563
  • [9] Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine
    Yang, BB
    Hounslow, NJ
    Sedman, AJ
    Forgue, ST
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04): : 356 - 360
  • [10] FOCUS ON SIMVASTATIN - A POTENT HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
    QUERCIA, RA
    HOSPITAL FORMULARY, 1989, 24 (10): : 559 - &
12345